Porphyria cutanea tarda: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{DiseaseDisorder infobox |
__NOTOC__
  Name        = Porphyria cutanea tarda |
{{Porphyria cutanea tarda}}
  ICD10      = {{ICD10|E|80|1|e|70}} |
{{CMG}}; {{AE}}
  ICD9        = {{ICD9|277.1}} |
}}
{{SI}}


{{CMG}}; {{AE}} {{KS}}
==[[Porphyria cutanea tarda overview|Overview]]==


==[[Porphyria cutanea tarda historical perspective|Historical Perspective]]==


==Overview==
==[[Porphyria cutanea tarda classification|Classification]]==
'''Porphyria cutanea tarda''' (PCT) is the most common subtype of [[porphyria]]. The disorder results from low levels of the [[enzyme]] responsible for the [[uroporphyrinogen III decarboxylase|fifth step]] in [[heme]] production. Heme is a vital molecule for all of the body's organs. It is a component of [[hemoglobin]], the molecule that carries [[oxygen]] in the blood.


==Presentation==
==[[Porphyria cutanea tarda pathophysiology|Pathophysiology]]==
When signs and symptoms occur, they usually begin in adulthood and result from the skin becoming overly sensitive to sunlight. Areas of skin exposed to the sun develop severe blistering, scarring, changes in pigmentation, and increased hair growth. Exposed skin becomes fragile and is easily damaged. People with porphyria cutanea tarda also have increased iron levels in the liver. They face a higher risk of developing abnormal liver function and liver cancer.<ref>{{cite journal | author=Fracanzani AL, Taioli E, Sampietro M, Fatta E, Bertelli C, Fiorelli G, Fargion S | title=Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease | journal=J Hepatol | year=2001 | pages=498-503 | volume=35 | issue=4  | id=PMID 11682034}}</ref>


==Causes==
==[[Porphyria cutanea tarda causes|Causes]]==
*In the acquired form, the signs and symptoms of this condition are triggered by non genetic factors such as alcohol abuse, excess iron, certain hormones, and viral infections. However, in the inherited form of the disease, which affects up to 20% of PCT patients, the condition arises from a mutation in the uroporphyrinogen decarboxylase gene, although environmental and chemical factors may trigger or exacerbate symptoms.
*Drug side effect: [[Chlorpropamide]], [[Tolbutamide]]


==Diagnosis==
==[[Porphyria cutanea tarda differential diagnosis|Differentiating Porphyria cutanea tarda from other Diseases]]==
===Physical Examination===
====Skin====
=====Extremities=====
<gallery>
 
Image:Porphyria cutanea tarda01.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
Image:Porphyria cutanea tarda02.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
Image:Porphyria cutanea tarda03.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
Image:Porphyria cutanea tarda04.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
 
 
Image:Porphyria cutanea tarda05.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
 
Image:Porphyria cutanea tarda06.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
 
 
Image:Porphyria cutanea tarda07.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
Image:Porphyria cutanea tarda08.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
Image:Porphyria cutanea tarda09.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
Image:Porphyria cutanea tarda11.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
 
Image:Porphyria cutanea tarda12.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
 
Image:Porphyria cutanea tarda13.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
 
Image:Porphyria cutanea tarda14.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
</gallery>
 
=====Face=====
<gallery>
 
 
Image:Porphyria cutanea tarda10.jpg|Porphyria cutanea tarda. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
 
 
</gallery>
 
==Epidemiology==
This type of porphyria occurs in an estimated 1 in 25,000 people, including both inherited and sporadic (noninherited) cases. An estimated 80 % of porphyria cutanea tarda cases are sporadic. The exact frequency is not clear because many people with the condition never experience symptoms.
 
==Genetics==
 
Inherited mutations in the ''[[UROD]]'' [[gene]] cause about 20 % of cases (the other 80 % of cases do not have [[mutation]]s in UROD, and are classified as sporadic). UROD makes an enzyme called [[uroporphyrinogen III decarboxylase]], which is critical to the chemical process that leads to heme production. The activity of this enzyme is usually reduced by 50 % in all tissues in people with the inherited form of the condition.


Nongenetic factors such as [[alcohol abuse]], excess [[iron]], and others listed above can increase the demand for heme and the enzymes required to make heme. The combination of this increased demand and reduced activity of uroporphyrinogen decarboxylase disrupts heme production and allows byproducts of the process to accumulate in the body, triggering the signs and symptoms of porphyria cutanea tarda.
==[[Porphyria cutanea tarda epidemiology and demographics|Epidemiology and Demographics]]==


The ''[[HFE]]'' gene makes a protein that helps cells regulate the absorption of iron from the digestive tract and into the cells of the body. Certain mutations in the ''HFE'' gene cause [[hemochromatosis]] (an [[iron overload disorder]]). People who have these mutations are also at an increased risk of developing porphyria cutanea tarda.
==[[Porphyria cutanea tarda risk factors|Risk Factors]]==


In the 20% of cases where porphyria cutanea tarda is inherited, it is inherited in an [[autosomal dominant]] pattern, which means one copy of the altered gene is sufficient to decrease enzyme activity and cause the signs and symptoms of the disorder.
==[[Porphyria cutanea tarda screening|Screening]]==


[[Image:autodominant.jpg|thumb|center|20% of cases of porphyria cutanea tarda are inherited in an [[autosomal dominant]] pattern.]]
==[[Porphyria cutanea tarda natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
===Physical Examination===
[[Porphyria cutanea tarda history and symptoms|History and Symptoms]] | [[Porphyria cutanea tarda physical examination|Physical Examination]] | [[Porphyria cutanea tarda laboratory findings|Laboratory Findings]] | [[Porphyria cutanea tarda electrocardiogram|Electrocardiogram]] |[[Porphyria cutanea tarda x ray|X Ray]] | [[Porphyria cutanea tarda CT|CT]] | [[Porphyria cutanea tarda MRI|MRI]] | [[Porphyria cutanea tarda echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Porphyria cutanea tarda other imaging findings|Other Imaging Findings]] | [[Porphyria cutanea tarda other diagnostic studies|Other Diagnostic Studies]]
====Skin====
<gallery>
 
 
Image:DiseaseName01.jpeg|DiseaseName. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/ Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
Image:DiseaseName
 
 
 
 
</gallery>


==Treatment==
==Treatment==
[[Chloroquine]] and [[venesection]] can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutanea tarda | journal=Clin Exp Dermatol | year=2001 | pages=225-32 | volume=26 | issue=3  | id=PMID 11422163}}</ref>
[[Porphyria cutanea tarda medical therapy|Medical Therapy]] | [[Porphyria cutanea tarda surgery|Surgery]] | [[Porphyria cutanea tarda primary prevention|Primary Prevention]] | [[Porphyria cutanea tarda secondary prevention|Secondary Prevention]] | [[Porphyria cutanea tarda cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Porphyria cutanea tarda future or investigational therapies|Future or Investigational Therapies]]
 
==Cultural references==
Porphyria Cutanea Tarda is also the name of a song by the punk band AFI on their album Black Sails in the Sunset.
 
==References==
<references/>
 
==Additional Resources==
* {{cite journal | author=Kauppinen R | title=Porphyrias | journal=Lancet | year=2005 | pages=241-52 | volume=365 | issue=9455  | id=PMID 15652607}}
* {{cite journal | author=Lecha M, Herrero C, Ozalla D | title=Diagnosis and treatment of the hepatic porphyrias | journal=Dermatol Ther | year=2003 | pages=65-72 | volume=16 | issue=1  | id=PMID 12919129}}
* {{cite journal | author=Nordmann Y, Puy H | title=Human hereditary hepatic porphyrias | journal=Clin Chim Acta | year=2002 | pages=17-37 | volume=325 | issue=1-2  | id=PMID 12367763}}
* {{cite journal | author=Sassa S | title=The porphyrias | journal=Photodermatol Photoimmunol Photomed | year=2002 | pages=56-67 | volume=18 | issue=2  | id=PMID 12147038}}
* [http://web.uct.ac.za/depts/porphyria/professional/prof-pct.htm "Porphyria Cutanea Tarda"] Porphyria South Africa, University of Cape Town/Groote Schurr Hospital
 


{{Vesiculobullous disease}}
==Case Studies==
{{Endocrine, nutritional and metabolic pathology}}
[[Porphyria cutanea tarda case study one|Case #1]]
{{SIB}}


[[de:Porphyria cutanea tarda]]
[[nl:Porphyria cutanea tarda]]
[[pt:Porfiria cutânea tarda]]
[[sr:Касна кожна порфирија]]


[[Category:Porphyrias]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Dermatology]]
[[Category:Genetic Disease]]
[[Category:Inborn errors of metabolism]]


{{WikiDoc Help Menu}}
{{WH}}
{{WikiDoc Sources}}
{{WS}}

Latest revision as of 20:28, 25 July 2016

Porphyria cutanea tarda Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Porphyria cutanea tarda from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Porphyria cutanea tarda On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Porphyria cutanea tarda

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Porphyria cutanea tarda

CDC on Porphyria cutanea tarda

Porphyria cutanea tarda in the news

Blogs on Porphyria cutanea tarda

Directions to Hospitals Treating Cushing’s disease

Risk calculators and risk factors for Porphyria cutanea tarda

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Porphyria cutanea tarda from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram |X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WH Template:WS